SEE STUDY RESULTS

ANORO was studied in patients with moderate or worse COPD.

ANORO improved lung function more than SPIRIVA and more than ADVAIR.

Individual results may vary. Each product has its own risks and benefits. Please see full Important Safety Information for ANORO ELLIPTA below.

  • ANORO is a dual bronchodilator that includes two medicines, a long-acting muscarinic antagonist (LAMA) and a long-acting beta2-adrenergic agonist (LABA).
  • SPIRIVA contains one medicine, a bronchodilator (LAMA).
  • ADVAIR contains two medicines, an inhaled corticosteroid (ICS) and a bronchodilator (LABA).

Based on results from 2 of 3 clinical trials comparing ANORO and SPIRIVA HANDIHALER. SPIRIVA is used to treat COPD and reduce COPD flare-ups.

Based on results from 2 clinical trials comparing ANORO and ADVAIR DISKUS 250/50. ADVAIR is used to treat COPD and reduce COPD flare-ups.

Talk to your doctor about ANORO, blue icon

TALK TO YOUR DOCTOR

Ready to talk to your doctor about treating your symptoms with ANORO? Follow this helpful guide for questions and tips.

Learn what to ask

If you have COPD, talk to your doctor about starting with once-daily ANORO.

Once-daily maintenance therapy

Once-daily maintenance therapy

Illustration of ANORO ELLIPTA Inhaler

2 medicines in 1 inhaler

Keep airways open for 24 hours

Keeps airways open for 24 hours

COPD patient talking to their doctor about ANORO

If you have COPD, talk to your doctor about starting with once-daily ANORO.

Once-daily maintenance therapy

Once-daily maintenance therapy

No hassle device with ANORO ELLIPTA Inhaler

2 medicines in 1 inhaler

Keep airways open for 24 hours

Keeps airways open for 24 hours

Illustration of ANORO savings

SAVE ON ANORO

 

If you're eligible, you can pay as little as $0 on ANORO.

 

For eligible commercially insured patients. Maximum savings of $190 per month between 1.1.2021 – 3.31.2021; and $150 per month at all other times. Restrictions apply.

See savings offer